NCT04043065View on ClinicalTrials.gov

Liver-enriched Antimicrobial Peptide 2

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 28, 2019

Primary Completion Date

May 20, 2019

Study Completion Date

May 20, 2019

Conditions
Type 2 Diabetes
Interventions
BIOLOGICAL

Liver-enriched antimicrobial peptide 2

Infusion of LEAP-2 during a 180 min grated glucose infusion.

OTHER

Placebo

Saline

Trial Locations (1)

2900

Center for Clinical Metabolic Research, Hellerup

Sponsors

Collaborators (1)

Gubra ApS
All Listed Sponsors
collaborator

Gubra ApS

UNKNOWN

lead

University Hospital, Gentofte, Copenhagen

OTHER

NCT04043065 - Liver-enriched Antimicrobial Peptide 2 | Biotech Hunter | Biotech Hunter